| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000008587 |
| Receipt No. | R000010088 |
| Official scientific title of the study | A multicenter, prospective, randomised study of "covered" versus "uncovered" stents for the management of distal malignant biliary obstruction |
| Date of disclosure of the study information | 2012/09/01 |
| Last modified on | 2017/11/23 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | A multicenter, prospective, randomised study of "covered" versus "uncovered" stents for the management of distal malignant biliary obstruction | |
| Title of the study (Brief title) | A multicenter randomized controlled trial of metallic stent for unresectable distal malignant biliary obstruction | |
| Region |
|
|
| Condition | ||
| Condition | Malignant biliary obstruction | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the patency and safety of Fully-covered versus Uncovered WallFlex stent for unresectable distal malignant biliary obstruction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Time to stent dysfunction |
| Key secondary outcomes | Effectiveness
1) Stent patency period 2) Survival period 3) Event free survival 4) Stent patency period after reintervention 5) Time to stent dysfunction after reintervention 6) Cost effectiveness Safety 1) Early complications 2) Late complications 3) Technical success rate 4) Removability of the stent 5) Removability of the second stent |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | WallFlex Fully-covered biliary stent | |
| Interventions/Control_2 | WallFlex Uncovered biliary stent | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients with unresectable distal malignant biliary obstruction, not limited to primary disease.
2) Patients with predictable prognosis of more than 4 months. 3) Patients with written informed consent. 4) Patients with performance status 0-3. |
|||
| Key exclusion criteria | 1) Patients with massive ascites.
2) Patients with severely impaired organ function. 3) Patients for whom endoscopic biliary drainage is difficult. 4) Patients with duodenal obstruction. 5) Patients whose antithrombotic drugs cannot be stopped. 6) Patients considered ineligible for this study. |
|||
| Target sample size | 200 | |||
| Research contact person | |
| Name of lead principal investigator | Tsutomu Chiba |
| Organization | Faculty of Medicine, Kyoto University |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto |
| TEL | 075-751-4319 |
| Public contact | |
| Name of contact person | Akira Kurita |
| Organization | Faculty of Medicine, Kyoto University |
| Division name | Department of Gastroenterology and Hepatology |
| Address | 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto |
| TEL | 075-751-4319 |
| Homepage URL | |
| akurita@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Faculty of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Faculty of Medicine, Kyoto University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010088 |